Spironolactone Tablets Market

Spironolactone is a type of diuretic medicine that is commonly used for the treatment of high blood pressure and heart failure. Diuretics are drugs that increase the output of urine from the kidneys. During, high blood pressure, these drugs expel the extra amount of fluid present in blood vessels, which ultimately lowers the elevated pressure. Since they help the kidneys to get rid of excess water and salts, the heart pumps the blood more easily thus treating heart failure. Spironolactone can also be used for treating the deficiency of potassium in people suffering from hypokalemia.
The spironolactone tablets market is anticipated to grow during the forecast period. According to the World Health Organization, cardiovascular diseases are one of the major causes of death in the global, leading to an estimated 17.9 million deaths annually. Most of these deaths are caused due to heart attacks and strokes. Since the prevalence of cardiovascular diseases has increased gradually in the last few years, it may act as a driving force for this market. There has been an increase in the geriatric population owing to an increase in life expectancy and a decreased fertility rate. This has caused an upsurge in hypertension cases, thus fueling the growth of this market. Also, the generality of kidney disorders and potassium deficiency in adults may help in the expansion of the market share.
Although the spironolactone tablets market is expected to flourish during the upcoming years, some factors may restrict the growth of the market. There are various side effects associated with the use of this drug. Some common side effects include dehydration, hyponatremia (low sodium levels), low blood pressure, and an increase in the level of potassium in the blood, called hyperkalemia. In severe cases, this may also be life-threatening. Some people may also experience a severe allergic reaction called anaphylaxis. Therefore, the dose must be adjusted carefully to prevent any harmful effects. In addition, there are various strict regulation policies concerning the use of diuretics, which have been imposed by the governing authorities for the safety of the users and may act as a hindrance to the growth of the market.
Technological advances are expected to provide lucrative opportunities for key players to increase their market share in the spironolactone tablets market. Novel drug delivery systems, like the synthesis of nanoparticles for better bioavailability and longer shelf life, are constantly under study. Various clinical trials and research to identify additional uses of spironolactone have been in action. Some experimentation includes the use of spironolactone for prostate conditions, Epstein–Barr virus, and some other conditions like rosacea. Other than this, there are rising cases of heart diseases and deaths linked to it. This is due to the changing lifestyle and lack of physical exercise, which may also provide new opportunities for the key players in the market.
New product launches to flourish in the market
In December 2021, a study had been published in the journal of the American Academy of Dermatology, introducing newer trends in prescribing spironolactone to adolescents suffering from hidradenitis suppurativa and acne. A repeated cross sectional analysis involving female subjects between the age groups of 13-19 years was included in this study. The use of spironolactone for HS and acne increased by two to three times across all age groups during the study period. It was also reported that the use of spironolactone increased with age and was almost ten times higher in 19-year-old women than in 13-year-old girls.
Segment Overview:
    
By application: The spironolactone tablets market is divided into high blood pressure (hypertension) and heart failure. Hypertension is a common condition in which the flow of blood through the arteries is very high. Due to this, there is more strain on the heart to pump blood. Hypertension may also act as a risk factor for heart failure. Globally, the prevalence of hypertension is very high owing to various factors. Therefore, this segment is likely to create opportunities for this market. 
By distribution channel: The spironolactone tablets market is categorized as hospitals pharmacies, retail pharmacies, and online. Retail pharmacies are expected to witness the highest growth during the forecast period. Hospitals dispense these drugs to both inpatients and outpatients. The market share for online pharmacies may also upsurge as it is more convenient for people to order their medicines online.
By region: The spironolactone market is segmented as North America, Europe, Asia-Pacific, and LAMEA. Out of these, North America witnessed the highest market share for this market in the past few years. The rising population in Asia-Pacific region, along with the awareness by various government organizations may expand the growth of the market in the upcoming years. Europe is anticipated to create new opportunities thus propelling the growth of the market.
Competitive analysis and profiles of the major players in the spironolactone tablets market, such as Accord Healthcare Ltd., Amneal Pharms, Aurobindo Pharma Ltd, For Daxia Healthcare Pvt. Ltd., Healthy Life Pharma Pvt. Ltd, Jubilant Generics Ltd., Mylan Nv, OXFORD PHARMS, Sun Pharmaceutical Industries Ltd., and Zydus Pharmaceuticals Ltd. are provided in this report. Some other key market players include divine savior healthcare. 

 Spironolactone Tablets Market Report Highlights

Aspects	Details
By Application	High blood pressure (Hypertension) Heart Failure
By Distribution Channel	Hospitals Pharmacies Retail Pharmacies Online
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	ACCORD HLTHCARE, AMNEAL PHARMS, Aurobindo Pharma Ltd, JUBILANT GENERICS LIMITED, Mylan Nv, OXFORD PHARMS, Sun Pharmaceutical Industries Ltd, zydus pharmaceuticals limited, Healthy Life Pharma Pvt Ltd, FOR DAXIA HEALTHCARE PVT.LTD
	divine savior healthcare